Correlation Between Kane Biotech and Rasna Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kane Biotech and Rasna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kane Biotech and Rasna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kane Biotech and Rasna Therapeutics, you can compare the effects of market volatilities on Kane Biotech and Rasna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kane Biotech with a short position of Rasna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kane Biotech and Rasna Therapeutics.

Diversification Opportunities for Kane Biotech and Rasna Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Kane and Rasna is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Kane Biotech and Rasna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rasna Therapeutics and Kane Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kane Biotech are associated (or correlated) with Rasna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rasna Therapeutics has no effect on the direction of Kane Biotech i.e., Kane Biotech and Rasna Therapeutics go up and down completely randomly.

Pair Corralation between Kane Biotech and Rasna Therapeutics

If you would invest  0.40  in Rasna Therapeutics on October 12, 2024 and sell it today you would earn a total of  0.00  from holding Rasna Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Kane Biotech  vs.  Rasna Therapeutics

 Performance 
       Timeline  
Kane Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kane Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's forward indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Rasna Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rasna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Rasna Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Kane Biotech and Rasna Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kane Biotech and Rasna Therapeutics

The main advantage of trading using opposite Kane Biotech and Rasna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kane Biotech position performs unexpectedly, Rasna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rasna Therapeutics will offset losses from the drop in Rasna Therapeutics' long position.
The idea behind Kane Biotech and Rasna Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format